Literature DB >> 10711355

Mechanisms of 17 beta-oestradiol induced vasodilatation in isolated pressurized rat small arteries.

L Shaw1, M J Taggart, C Austin.   

Abstract

1. The influence of 17 beta-oestradiol on pressurized isolated rat mesenteric and coronary small arteries was investigated. 2. 17 beta-oestradiol caused rapid (t1.0 < 5 mins) concentration-dependent relaxations of pre-contracted pressurized (50 mmHg) isolated rat mesenteric and coronary arteries. Similar responses were observed in both vessel types. Significant relaxations were only observed at concentrations exceeding 3 microM. 3. The vasodilatory responses in both types of artery were unaffected by 10 microM L-nitro arginine (L-NNA) alone or in the presence of 10 microM indomethacin, inhibitors of nitric oxide and prostaglandin synthesis respectively. They were also unaffected by the pre-contracting agent used i.e. high K+ or U46619 (a thromboxane analogue). 4. Neither the oestrogen receptor antagonist ICI 182,780 (10 microM) nor the protein synthesis inhibitor cycloheximide (100 microM) had any effect on the responses of mesenteric arteries to 17 beta-oestradiol. 5. 17 alpha-oestradiol had only a minor effect on mesenteric arterial diameter over a concentration range similar to the effective vasodilatory range for 17 beta-oestradiol. 6. Membrane impermeant 17 beta-oestradiol conjugated to bovine serum albumin (beta-oestradiol-17-hemisuccinate-BSA) (E-H-BSA) resulted in a vasodilatation of pressurized arteries. 7. Wortmannin, an inhibitor of myosin light chain kinase, near maximally relaxed pressurized mesenteric arteries although the time course for the response was significantly slower than that for 17 beta-oestradiol. 8. These results taken together suggest that the acute effects of 17 beta-oestradiol on isolated pressurized arterial tone may be due to effects directly on the vascular smooth muscle via non-genomic mechanisms that involve a stereospecific interaction at the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10711355      PMCID: PMC1571867          DOI: 10.1038/sj.bjp.0703084

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  63 in total

1.  Arachidonic acid inhibits myosin light chain phosphatase and sensitizes smooth muscle to calcium.

Authors:  M C Gong; A Fuglsang; D Alessi; S Kobayashi; P Cohen; A V Somlyo; A P Somlyo
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

Review 2.  ICI 182,780, a new antioestrogen with clinical potential.

Authors:  A E Wakeling; J Bowler
Journal:  J Steroid Biochem Mol Biol       Date:  1992-09       Impact factor: 4.292

3.  Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy.

Authors:  D M Herrington; G A Braden; J K Williams; T M Morgan
Journal:  Am J Cardiol       Date:  1994-05-15       Impact factor: 2.778

4.  Enhanced resistance artery sensitivity to agonists under isobaric compared with isometric conditions.

Authors:  W R Dunn; G C Wellman; J A Bevan
Journal:  Am J Physiol       Date:  1994-01

5.  17Beta-estradiol stimulates flow-induced vasodilatation in isolated small mesenteric arteries from prepubertal femal rats.

Authors:  A P Cockell; L Poston
Journal:  Am J Obstet Gynecol       Date:  1997-12       Impact factor: 8.661

6.  Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.

Authors:  D M Gilligan; A A Quyyumi; R O Cannon
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

7.  Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women.

Authors:  D W Losordo; M Kearney; E A Kim; J Jekanowski; J M Isner
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

8.  Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.

Authors:  S E Reis; S T Gloth; R S Blumenthal; J R Resar; H A Zacur; G Gerstenblith; J A Brinker
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

9.  Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro.

Authors:  A Mügge; M Riedel; M Barton; M Kuhn; P R Lichtlen
Journal:  Cardiovasc Res       Date:  1993-11       Impact factor: 10.787

10.  Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women.

Authors:  D M Gilligan; D M Badar; J A Panza; A A Quyyumi; R O Cannon
Journal:  Am J Cardiol       Date:  1995-02-01       Impact factor: 2.778

View more
  21 in total

1.  Acute effects of oestrogen receptor subtype-specific agonists on vascular contractility.

Authors:  Sandra Montgomery; Linda Shaw; Nick Pantelides; Michael Taggart; Clare Austin
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

2.  Structural analysis of estrogen receptors: interaction between estrogen receptors and cav-1 within the caveolae†.

Authors:  Mayra B Pastore; Rosalina Villalon Landeros; Dong-Bao Chen; Ronald R Magness
Journal:  Biol Reprod       Date:  2019-02-01       Impact factor: 4.285

3.  Vasorelaxant effect of 17α-ethynylestradiol on human saphenous vein.

Authors:  Ahmad Reza Jodati; Hossein Babaei; Yadollah Azarmi; Sahar Fallah; Afsaneh Gharebageri; Danial Fadaei Fouladi; Naser Safaei
Journal:  Adv Pharm Bull       Date:  2015-03-05

Review 4.  The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function.

Authors:  Matthias R Meyer; Eric R Prossnitz; Matthias Barton
Journal:  Vascul Pharmacol       Date:  2011-07-05       Impact factor: 5.773

5.  Effects of the oestrous cycle and gender on acute vasodilatory responses of isolated pressurized rat mesenteric arteries to 17 beta-oestradiol.

Authors:  L Shaw; M Taggart; C Austin
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

6.  17β-Estradiol induces vasorelaxation in a G-protein-coupled receptor 30-independent manner.

Authors:  Young Mi Seok; Eun Jin Jang; Oliver Reiser; Markus Hager; In Kyeom Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-06-12       Impact factor: 3.000

7.  17beta-estradiol attenuates vascular contraction through inhibition of RhoA/Rho kinase pathway.

Authors:  Enyue Yang; Su Bun Jeon; Inji Baek; Zheng-Ai Chen; Zheng Jin; In Kyeom Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-03-19       Impact factor: 3.000

8.  GPER/GPR30 and Regulation of Vascular Tone and Blood Pressure.

Authors:  Matthias R Meyer; Eric R Prossnitz; Matthias Barton
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2011

9.  Estrogen replacement restores flow-induced vasodilation in coronary arterioles of aged and ovariectomized rats.

Authors:  Amanda J LeBlanc; Rafael Reyes; Lori S Kang; Robert A Dailey; John N Stallone; Natasha C Moningka; Judy M Muller-Delp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-10-07       Impact factor: 3.619

10.  Comparison of U46619-, endothelin-1- or phenylephrine-induced changes in cellular Ca2+ profiles and Ca2+ sensitisation of constriction of pressurised rat resistance arteries.

Authors:  Linda Shaw; Stephen O'Neill; Carolyn J P Jones; Clare Austin; Michael J Taggart
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.